欧洲抗击癌症计划在行动：面向未来的国家实施

National Implementation for the Future EFPIA Oncology Platform and Cancer Patients Europe Europe’s Beating Cancer Plan in Action: National Implementation for the Future•EFPIA Oncology Platform and Cancer Patients Europe Executive summary This report evaluates the alignment of National CancerControl Programmes (NCCPs) with Europe’s Beating CancerPlan (EBCP), focusing on six Member States: France, Spain,Germany, Denmark, Hungary, and Slovakia. It explores howaligning national cancer strategies with the EBCP can driveimprovements across cancer prevention, early detection,diagnosis, treatment, and survivorship. The report identifiesvarying levels of alignment with EBCP priorities, highlightskey challenges, and provides tailored policy recommendationsfor both national and EU-level stakeholders. •Archetype B (Germany, Denmark): These countrieshave robust cancer control strategies, but their NCCPsare in various stages of development or revision. Whilethey show a strong commitment to EBCP goals, somegaps remain in areas such as paediatric cancer care,comprehensive monitoring systems, and integration ofpersonalised medicine across all regions. Both countrieshave made progress in aligning with EBCP objectives butcontinue to face challenges in funding and ensuring fullimplementation across all regions. •Archetype C (Hungary, Slovakia): These countries faceconsiderable challenges in updating and implementingtheir NCCPs. Gaps include limited funding, lack of com-prehensive integration of EBCP priorities, and unequalaccess to high-quality cancer care. While both countriesare involved in some pilot projects and are slowly mak-ing progress, the overall implementation of their cancercontrol strategies remains fragmented. There is a needfor targeted support to address these gaps and improveintegration with EU-level initiatives. Key findings across three archetypes of countries revealsignificant differences in alignment: •Archetype A (France, Spain): These countries demon-strate the strongest alignment with EBCP priorities. Bothhave comprehensive governance structures, well-es-tablished cancer control plans, and dedicated fundingstreams. They excel in prevention, screening, personalisedmedicine, and research integration. Notably, France’sNCCP has a ten-year horizon, with a strong commitmentto funding and stakeholder involvement, while Spainaligns closely with EBCP objectives and has integratedkey cross-cutting themes such as cancer inequalities andpaediatric cancer care. Europe’s Beating Cancer Plan in Action: National Implementation for the Future•EFPIA Oncology Platform and Cancer Patients Europe The report includes policy recommendations for European Union institutions and Member States to ensure na-tional implementation of the EBCP: National: Funding and governance •Protect and ring-fence multi-year NCCP funding lines through national budget laws or dedicated funds. •Leverage ongoing revisions of national cancer plans to strengthen alignment with Europe’s Beating Cancer Plan (EBCP)priorities, including inequalities, paediatric cancer, and personalised medicine.•Require regional and national plans to include explicit measures to reduce within-country disparities and embed equityand paediatric cancer measures with targeted interventions for vulnerable groups.•Publish updated KPI lists within a transparent monitoring and reporting framework, developed with broad stakeholderinput, and accompanied by implementation roadmaps that include measurable milestones Prevention •Adopt comprehensive laws that extend smoke- and aerosol-free protections to priority outdoor settings and ensure parityacross all nicotine and tobacco products, supported by strong enforcement. •Introduce or strengthen school-based, gender-neutral HPV vaccination programmes with reminder systems, ensuringequitable access and sustained progress towards the EBCP 2030 target of 90% coverage. Screening and early detection •Ensure all screening programmes are fully aligned with European Commission Initiative guidelines, and support systematicpiloting of new programmes (e.g., prostate, gastric) where feasible.•Move successful pilots (e.g., low-dose CT for lung cancer) into national programmes and support the uptake of innovativescreening technologies and risk-stratification measures. Treatment and personalised medicine •Develop national precision medicine implementation roadmaps with measurable milestones, stakeholder-validated KPIs,and clear decision rules for scaling successful pilots into standard care. Research and investment •Strengthen national cancer networks by integrating Comprehensive Cancer Centres (CCCs) as hubs for high-qualityand equitable care. European: Funding and governance •Adopt an EU National Cancer Control Plan (NCCP) Minimum Standard Framework that sets progressive milestones forgovernance, financing, KPIs, and data interoperability; includes a compact, EBCP-aligned KPI set (e.g., screening cover-age, diagnostic timeli